Overview

Long-term Pleiotropic Effect of Statins in Patients With Peripheral Arterial Disease

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine the long-term effects of statins, atorvastatin, upon Nitric Oxide, as an endothelial function assessment, and C-Reactive Protein, an inflammatory marker, levels in patients with Peripheral Arterial Disease. These long-term biological pleiotropic effects of statins will offer information on the role of endothelial function and systemic inflammation in the etiopathogenesis of PAD.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Hospital Universitario Getafe
Treatments:
Atorvastatin
Atorvastatin Calcium
Criteria
Inclusion Criteria:

- patients at the time of diagnosis of Fontaine grade II peripheral arterial disease
(PAD), confirmed by hemodynamic evaluation (Doppler ultrasound)

- over 18 years old

Exclusion Criteria:

- patients had previously undergone revascularization

- patients were receiving treatment with statins

- patients with contraindications to statin use.

- patients with coexistence of chronic inflammatory diseases or steroidal medication